Pharma Equity Group A/S

Pharma Equity Group A/S EBITDA per Share

The EBITDA per Share of Pharma Equity Group A/S (PEG.CO) as of Oct 15, 2026 is -0.02 DKK. In the previous year, EBITDA per Share was -0.02 DKK — a change of -15.16% (higher).

EBITDA per Share

-0.02DKK

YoY

-15.16%

Last updated:

EBITDA per Share of Pharma Equity Group A/S is 2025 -0.02 DKK. EBITDA per Share of Pharma Equity Group A/S was 2024 -0.02 DKK. It decreases by -15.16% higher compared to the previous year.

The Pharma Equity Group A/S EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-0.00 DKK
Jan 1, 2019
-0.00 DKK
Jan 1, 2020
-0.01 DKK
Jan 1, 2021
-0.00 DKK
Jan 1, 2022
0.00 DKK
Jan 1, 2023
-0.02 DKK
Jan 1, 2024
-0.02 DKK
Jan 1, 2025
-0.02 DKK
The Pharma Equity Group A/S EBITDA per Share history
YEAREBITDA per ShareYoY
-0.02DKK-15.16%
-0.02DKK-15.82%
-0.02DKK-873.87%
0.00DKK-371.61%
-0.00DKK-91.80%
-0.01DKK+953.92%
-0.00DKK-0.12%
-0.00DKK-15.63%
-0.00DKK-98.00%
-0.08DKK+201.00%
-0.03DKK-56.16%
-0.06DKK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pharma Equity Group A/S Stock analysis

What does Pharma Equity Group A/S do? Blue Vision A/S is a company specializing in the development, production, and marketing of underwater technology. It was founded in 1992 and is headquartered in Holstebro, Denmark. The company focuses on underwater lighting, underwater inspection cameras, and underwater communication. It specializes in manufacturing underwater lighting products for the offshore industry, ports, and shipping. It also produces underwater inspection cameras for inspecting underwater structures without the need for divers. In addition, the company has developed devices for underwater communication, which are crucial in the offshore industry and military sector. Blue Vision A/S emphasizes innovation and technology, holding patents and investing in digital technology to improve inspection systems. In summary, Blue Vision A/S specializes in underwater technology and offers solutions for the offshore industry, ports, and shipping. The company is committed to innovation and technology to provide the best solutions to its customers. Pharma Equity Group A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pharma Equity Group A/S stock

EBITDA per Share of Pharma Equity Group A/S is -0.02 DKK in 2025.

EBITDA per Share of Pharma Equity Group A/S changed from -0.02 DKK to -0.02 DKK, representing a -15.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Pharma Equity Group A/S since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Pharma Equity Group A/S

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Pharma Equity Group A/S